The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

The Centers for Disease Control and Prevention says that the Federal Drug Administration has ended a program that provided ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Key Takeaways Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 ...

Moderna’s Spikevax and Pfizer’s Comirnaty are available at GIANT and MARTIN’S pharmacies — inventory may vary by location. Vaccines for those 12 years and older are readily available. Vaccines for ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...

The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at least 25 U.S. states, according to reports.